<Suppliers Price>

Methylstat

Names

[ CAS No. ]:
1310877-95-2

[ Name ]:
Methylstat

[Synonym ]:
2-Butenoic acid, 4-[hydroxy[4-[[[4-[[[(1-naphthalenylamino)carbonyl]oxy]methyl]phenyl]methyl]amino]butyl]amino]-4-oxo-, methyl ester, (2E)-
4-[hydroxy-[4-[[4-[[(1-naphthalenylamino)-oxomethoxy]methyl]phenyl]methylamino]butyl]amino]-4-oxo-2-butenoic acid methyl ester
Methyl (2E)-4-(hydroxy{4-[(4-{[(1-naphthylcarbamoyl)oxy]methyl}benzyl)amino]butyl}amino)-4-oxo-2-butenoate

Biological Activity

[Description]:

Methylstat is a potent histone demethylases inhibitor. Methylstat shows anti-proliferative activity with low cytotoxicity. Methylstat induces apoptosis and cell cycle arrest at G0/G1 phase. Methylstat increases the expression of p53 and p21 protein levels. Methylstat inhibits angiogenesis induced by various cytokines. Methylstat can be used as a chemical probe for addressing its role in angiogenesis[1][2].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis
Research Areas >> Cancer
Research Areas >> Cardiovascular Disease
Signaling Pathways >> Apoptosis >> MDM-2/p53
Signaling Pathways >> Epigenetics >> Histone Demethylase

[In Vitro]

Methylstat (0-5 µM; 48, 72 h) shows anti-proliferative activity with no cytotoxicity on HUVECs at 1-2 µM[1]. Methylstat (0, 1, 2 µM; 48 h) induces cell cycle arrest at G0/G1 phase in a dose-dependent manner[1]. Methylstat (0, 1, 2 µM; 48 h) increases the expression of p53 mRNA levels, the H3K27 methylation levels and the accumulation of p53 and p21 protein levels, but suppresses the protein level of cyclinD1[1]. Methylstat (0, 1, 2 µM) shows anti-angiogenic activity induced by VEGF, bFGF and TNF-α in HUVEC cells, and inhibits the f capillary formation during CAM (chick embryo chorioallantoic membrane) development without any sign of thrombosis and hemorrhage[1]. Methylstat (1.1, 2.2 mM for U266 cells, 2.1, 4.2 mM for ARH77 cells; 72 h) induces apoptosis significantly in U266 and ARH77 cells[2]. Cell Cytotoxicity Assay[1] Cell Line: HUVEC cells Concentration: 0-5 µM Incubation Time: 48, 72 h Result: Did not exhibit cytotoxicity on HUVECs at 1-2 µM. Cell Viability Assay[1] Cell Line: HUVEC, HepG2, HeLa, CHANG cells Concentration: 0-5 µM Incubation Time: 72 h Result: Showed anti-proliferative activity with IC50s of 4, 10, 5, 7.5 µM for HUVEC, HepG2, HeLa, CHANG cells, respectively. Cell Cycle Analysis[1] Cell Line: HUVEC cells Concentration: 0, 1, 2 µM Incubation Time: 48 h Result: G0/G1 phase increased 16.8% compared to non-treated cells, whereas S andG2/M decreased 5.5% and 6.1% respectively. Western Blot Analysis[1] Cell Line: HUVEC cells Concentration: 0, 1, 2 µM Incubation Time: 0-48 h Result: Resulted in accumulation of p53 and p21 protein levels in a time- and dose-dependent manner and increased the H3K27 methylation levels, the but suppressed the protein level of cyclinD1. Apoptosis Analysis[2] Cell Line: U266, ARH77 cells Concentration: 1.1, 2.2 mM for U266 cells, 2.1, 4.2 mM for ARH77 cells Incubation Time: 72 h Result: Induced apoptosis in U266, ARH77 cells.

[References]

[1]. Yumi Cho, et al. A histone demethylase inhibitor, methylstat, inhibits angiogenesis in vitro and in vivo. RSC Advances, 2014.

[2]. Kacı FN, et al. Synergistic Apoptotic Effects of Bortezomib and Methylstat on Multiple Myeloma Cells. Arch Med Res. 2020 Apr;51(3):187-193.

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Molecular Formula ]:
C28H31N3O6

[ Molecular Weight ]:
505.562

[ Exact Mass ]:
505.221283

[ LogP ]:
3.30

[ Index of Refraction ]:
1.635

Safety Information

[ RIDADR ]:
NONH for all modes of transport


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.